Medicare Part D Redesign Savings May Be Lower For Beneficiaries With Spending Below The Out-Of-Pocket Cap.
The Medicare prescription drug plan redesign under the Inflation Reduction Act of 2022 aims to simplify the Part D benefit while capping out-of-pocket spending for Part D--covered drugs. Whether and which Medicare beneficiaries will see savings from the redesigned benefit is unclear.We evaluated pla...
| Publicado en: | Health Affairs Vol. 44; no. 6; pp. 650 - 659 |
|---|---|
| Autores principales: | , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Health Affairs Publishing, LLC
Jun2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |